Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2576-2582

  Ghiasi, Homayon ^a,b   Hofman, Florence M ^c   Cai, Steve ^a   Perng, Guey Cheun ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Corneal scarring; Cytokines; HSV 1; T helper; Vaccination

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CORNEA DISEASE; DELAYED HYPERSENSITIVITY; HELPER CELL; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS EXPRESSION;

EID: 0033522837     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00056-0     Document Type: Article

References (54)

1. H2 phenotype during the development of collagen-induced arthritis. Eur J Immunol. 27:1997;1451-1458.
2. H2-like phenotype. J Exp Med. 179:1994;481-491.
3. H0 cells in the thymus: the question of T-helper lineages. Immunol Rev. 123:1991;169-188.
4. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone, I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348-2357.
5. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
6. + T cells acquire specific lymphokine secretion potentials during thymic maturation. Nature. 353:1991;68-71.
7. Ghiasi H., Wechsler S.L., Kaiwar R., Nesburn A.B., Hofman F.M. Local expression of tumor necrosis factor-α and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J Virol. 69:1995;334-340.
8. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:1989;145-173.
9. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
10. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA. 89:1992;6065-6069.
11. H2 cells. J Immunol. 148:1992;3820-3829.
12. + T cells. Annu Rev Immunol. 12:1994;635-673.
13. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med. 172:1990;921-929.
14. + T cells through IL-12 produced by Listeria-induced macrophages [see comments]. Science. 260:1993;547-549.
15. + T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int Immunol. 5:1993;1119-1128.
16. H1 cell development. Science. 271:1996;984-987.
17. Ghiasi H., Slanina S., Nesburn A.B., Wechsler S.L. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. J Virol. 68:1994;2347-2354.
18. Ghiasi H., Cai S., Slanina S., Nesburn A.B., Wechsler S.L. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Invest Ophthalmol Vis Sci. 38:1997;1213-1221.
19. Ghiasi H., Nesburn A.B., Kaiwar R., Wechsler S.L. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch Virol. 121:1991;163-178.
20. Ghiasi H., Kaiwar R., Nesburn A.B., Wechsler S.L. Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge. Virology. 190:1992;233-239.
21. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol. 68:1994;2118-2126.
22. + T-helper cells in mycosis fungoides and the Sezary syndrome. Am J Dermatopathol. 5:1983;135-143.
23. H2 cytokine response in human tuberculosis. Infect Immun. 64:1996;1351-1356.
24. Hofman F.M., Hinton D.R. Tumor necrosis factor-α in the retina in acquired immune deficiency syndrome. Invest Ophthalmol Vis Sci. 33:1992;1829-1835.
25. H0 cells. Science. 265:1994;244-248.
26. Maruyama T., Schodel F., Iino S., Koike K., Yasuda K., Peterson D., Milich D.R. Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology. 106:1994;1006-1015.
27. H2 cells is epitope and major histocompatibility complex dependent. J Virol. 69:1995;2776-2785.
28. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med. 180:1994;1273-1282.
29. Babu J.S., Kanangat S., Rouse B.T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 154:1995;4822-4829.
30. Niemialtowski M.G., Rouse B.T. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol. 148:1992;1864-1870.
31. H2 type T cells. J Immunol. 151:1993;5777-5789.
32. H2-T-cell line induces HSV-1 keratitis. Ophthalmologe. 92:1995;484-491.
33. Carmack M.A., Yasukawa L.L., Chang S.Y., Tran C., Saldana F., Arvin A.M., Prober C.G. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis. 174:1996;899-906.
34. Manickan E., Kanangat S., Rouse R.J., Yu Z., Rouse B.T. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol. 61:1997;125-132.
35. Binder P.S. A review of the treatment of ocular herpes simplex infections in the neonate and immunocompromised host. Cornea. 3:1984;178-182.
36. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol. 70:1996;898-904.
37. Oakes J.E., Monteiro C.A., Cubitt C.L., Lausch R.N. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J Virol. 67:1993;4777-4784.
38. Chen S.H., Oakes J.E., Lausch R.N. Synergistic anti-herpes effect of TNF-α and IFN-γ in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 25:1994;201-213.
39. Tran M.T., Tellaetxe-Isusi M., Elner V., Strieter R.M., Lausch R.N., Oakes J.E. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells: β-chemokine synthesis in corneal cells. Invest Ophthalmol Vis Sci. 37:1996;987-996.
40. Easty D.L., Shimeld C., Claoue C.M., Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res. 6:1987;69-74.
41. Yan X.T., Tumpey T.M., Kunkel S.L., Oakes J.E., Lausch R.N. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 39:1998;1854-1862.
42. Tumpey T.M., Cheng H., Cook D.N., Smithies O., Oakes J.E., Lausch R.N. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J Virol. 72:1998;3705-3710.
43. Tumpey T.M., Cheng H., Yan X.T., Oakes J.E., Lausch R.N. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol. 63:1998;486-492.
44. Tumpey T.M., Elner V.M., Chen S.H., Oakes J.E., Lausch R.N. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol. 153:1994;2258-2265.
45. Ghiasi H., Wechsler S.L., Cai S., Nesburn A.B., Hofman F.M. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology. 95:1998;352-359.
46. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol. 149:1992;3023-3028.
47. Popko B., Corbin J.G., Baerwald K.D., Dupree J., Garcia A.M. The effects of interferon-γ on the central nervous system. Mol Neurobiol. 14:1997;19-35.
48. Geiger K., Howes E.L., Sarvetnick N. Ectopic expression of γ-interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections. J Virol. 68:1994;5556-5567.
49. Ghiasi H., Bahri S., Nesburn A.B., Wechsler S.L. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci. 36:1995;1352-1360.
50. H1-associated function in peripheral T cells but not thymocytes in tolerance to major histocompatibility complex alloantigen. Immunology. 79:1993;556-561.
51. Ruzek M.C., Mathur A. In vitro and in vivo recovery of IFN-γ, but not IL-2, production by IL-12 in mice with plasma cell tumors. Int Immunol. 8:1996;413-422.
52. + TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J Exp Med. 182:1995;1505-1515.
53. Assenmacher M., Schmitz J., Radbruch A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells. Eur J Immunol. 24:1994;1097-1101.
54. + T cell subset. Eur J Immunol. 28:1998;3630-3638.